About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Ptpn11tm1Bgn
targeted mutation 1, Benjamin G Neel
MGI:3050284
Summary 6 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Ptpn11tm1Bgn/Ptpn11tm1Bgn involves: 129S4/SvJae * C57BL/6J MGI:3050465
ht2
Ptpn11tm1Bgn/Ptpn11+ 129S6.129S4-Ptpn11tm1Bgn MGI:3840263
ht3
Ptpn11tm1Bgn/Ptpn11+ B6.129S4-Ptpn11tm1Bgn MGI:3840262
ht4
Ptpn11tm1Bgn/Ptpn11+ C.129S4-Ptpn11tm1Bgn MGI:3840261
ht5
Ptpn11tm1Bgn/Ptpn11+ involves: 129S4/SvJae * C57BL/6 MGI:3840260
ht6
Ptpn11tm1Bgn/Ptpn11+ involves: 129S4/SvJae * C57BL/6J MGI:3050469


Genotype
MGI:3050465
hm1
Allelic
Composition
Ptpn11tm1Bgn/Ptpn11tm1Bgn
Genetic
Background
involves: 129S4/SvJae * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpn11tm1Bgn mutation (1 available); any Ptpn11 mutation (43 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• homozygous embryos die around E13.5

cardiovascular system
• the myocardium is markedly thinner compared to wild-type
• enlarged outflow tract and atrioventricular valve primordia are seen
• at E13.5 atrial septal defects are seen
• at E13.5 atrioventricular septal defects are seen
• at E13.5 ventricular and atrioventricular septal defects are seen
• pericardial effusions are seen
• at E13.5 embryos are grossly hemorrhagic
• decreased apoptosis is seen in endocardial cushions

cellular
• decreased apoptosis is seen in endocardial cushions
• at E13.5 severe liver necrosis is seen
• increased cellular proliferation is seen in endocardial cushions

homeostasis/metabolism
• pericardial effusions are seen
• at E13.5 embryos are grossly edematous with pericardial and peritoneal effusions and subcutaneous edema

liver/biliary system
• at E13.5 severe liver necrosis is seen
• at E13.5 decreased liver size is seen

muscle
• the myocardium is markedly thinner compared to wild-type
• decreased apoptosis is seen in endocardial cushions




Genotype
MGI:3840263
ht2
Allelic
Composition
Ptpn11tm1Bgn/Ptpn11+
Genetic
Background
129S6.129S4-Ptpn11tm1Bgn
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpn11tm1Bgn mutation (1 available); any Ptpn11 mutation (43 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
N
• Background Sensitivity: unlike mice on a congenic C57BL/6 background nearly all mice survive




Genotype
MGI:3840262
ht3
Allelic
Composition
Ptpn11tm1Bgn/Ptpn11+
Genetic
Background
B6.129S4-Ptpn11tm1Bgn
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpn11tm1Bgn mutation (1 available); any Ptpn11 mutation (43 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• Background Sensitivity: penetrance of lethality is increased compared to mice on a 129S6/SvEv or BALB/c congenic background and to mice on a mixed 129S4/SvJae and C57BL/6 background
• almost all mice die

cardiovascular system
• all mice show severe cardiac defects




Genotype
MGI:3840261
ht4
Allelic
Composition
Ptpn11tm1Bgn/Ptpn11+
Genetic
Background
C.129S4-Ptpn11tm1Bgn
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpn11tm1Bgn mutation (1 available); any Ptpn11 mutation (43 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• about 50% of mice die either in late gestation or perinatally
• Background Sensitivity: penetrance of lethality is decreased compared to mice on a congenic C57BL/6 background




Genotype
MGI:3840260
ht5
Allelic
Composition
Ptpn11tm1Bgn/Ptpn11+
Genetic
Background
involves: 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpn11tm1Bgn mutation (1 available); any Ptpn11 mutation (43 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• about 50% of mice die either in late gestation or perinatally
• Background Sensitivity: penetrance of lethality is decreased compared to mice on a congenic C57BL/6 background

cardiovascular system
• from 24 - 48 hours in culture endocardial cushions from E9.5 embryos give rise to more mesenchymal cells compared to wild-type controls
• expression analysis indicates that enhanced production of mesenchymal cells is due to a prolongation of the normal interval during which EMT occurs

growth/size/body

hematopoietic system
• increase in the number of CFU-GM in the absence of cytokines compared to wild-type controls

vision/eye
• increased inner canthal distance




Genotype
MGI:3050469
ht6
Allelic
Composition
Ptpn11tm1Bgn/Ptpn11+
Genetic
Background
involves: 129S4/SvJae * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpn11tm1Bgn mutation (1 available); any Ptpn11 mutation (43 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• at E18.5 some heterozygous embryos are dead and about 50% fewer than expected heterozygotes are found at weaning

cardiovascular system
• enlarged atrioventricular valve primordia are seen in about 50% of heterozygotes (severely affected mutants)
• double outlet right ventricle is seen in about 50% of heterozygotes (severely affected mutants)
• enlarged mitral valves are seen in about 50% of heterozygotes (not severely affected) at E13.5 but not at E18.5
• at E13.5 ventricular septal defects are seen in about 50% of heterozygotes (severely affected mutants)
• decreased apoptosis is seen in endocardial cushions from some heterozygous mutants

cellular
• decreased apoptosis is seen in endocardial cushions from some heterozygous mutants
• at E13.5 some heterozygotes display mild liver damage
• increased cellular proliferation is seen in endocardial cushions from some heterozygous mutants

craniofacial
• consistent with the decreased body size the skull is smaller than normal however width is not different from wild-type resulting in a greater length/width ratio
• a wider and blunter snout shape is seen
• a wider and blunter snout shape is seen

growth/size/body
• a wider and blunter snout shape is seen
• a wider and blunter snout shape is seen
• a significant reduction in body weight and length is seen without altering overall body proportions
• a significant reduction in body weight and length is seen without altering overall body proportions
• older heterozygotes develop splenomegaly with mild myeloid and erythroid hyperplasia

hematopoietic system
• older heterozygotes develop splenomegaly with mild myeloid and erythroid hyperplasia
• mild myeloid hyperplasia is seen in the bone marrow of older heterozygotes
• by 5 months heterozygotes develop mild leukocytosis with normal hematocrit and platelet counts

immune system
• older heterozygotes develop splenomegaly with mild myeloid and erythroid hyperplasia
• mild myeloid hyperplasia is seen in the bone marrow of older heterozygotes
• by 5 months heterozygotes develop mild leukocytosis with normal hematocrit and platelet counts

liver/biliary system
• at E13.5 some heterozygotes display mild liver damage

skeleton
• consistent with the decreased body size the skull is smaller than normal however width is not different from wild-type resulting in a greater length/width ratio

muscle
• decreased apoptosis is seen in endocardial cushions from some heterozygous mutants

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Noonan syndrome 1 DOID:0060578 OMIM:163950
J:91609





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory